Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Schependom, M. D'hooghe, Krista Cleynhens, M. D'hooge, Marie-Claire Haelewyck, De Keyser, De Keyser, G. Nagels (2014)
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosisEuropean Journal of Neurology, 21
(1983)
The hospital anxiety and depression scaleActa Psychiatr Scand, 67
A. Smith (2016)
Symbol Digit Modalities Test
L. Kappos, M. D’Souza, J. Lechner-Scott, C. Lienert (2015)
On the origin of Neurostatus.Multiple sclerosis and related disorders, 4 3
J. Fredrickson, P. Maruff, M. Woodward, L. Moore, A. Fredrickson, J. Sach, D. Darby (2009)
Evaluation of the Usability of a Brief Computerized Cognitive Screening Test in Older People for Epidemiological StudiesNeuroepidemiology, 34
Jeffrey Cohen, S. Reingold, C. Polman, J. Wolinsky (2012)
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospectsThe Lancet Neurology, 11
F. Mattioli, F. Bellomi, C. Stampatori, R. Capra, C. Miniussi (2016)
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosisMultiple Sclerosis Journal, 22
M. Shawaryn, KM Schiaffino, NG LaRocca, MV Johnston (2002)
Determinants of health-related quality of life in multiple sclerosis: the role of illness intrusivenessMultiple Sclerosis, 8
J. Campbell, D. Langdon, M. Cercignani, W. Rashid (2016)
A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI StudyNeural Plasticity, 2016
P. Hoang, D. Schoene, S. Gandevia, Stuart Smith, S. Lord (2016)
Effects of a home-based step training programme on balance, stepping, cognition and functional performance in people with multiple sclerosis – a randomized controlled trialMultiple Sclerosis Journal, 22
D. Langdon, M. Amato, J. Boringa, B. Brochet, F. Foley, S. Fredrikson, P. Hämäläinen, H. Hartung, L. Krupp, I. Penner, A. Reder, R. Benedict (2012)
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)Multiple Sclerosis (Houndmills, Basingstoke, England), 18
(2000)
San Antonio: The Psychological Corporation
Anna Carone, S. D'Amore, Livia Albanese, Francesco Craig, P. Scagliusi, M. D’amore (2011)
[Hospital anxiety and depression].Reumatismo, 59 4
R. Benedict, S. Morrow, Jonathan Rodgers, D. Hojnacki, M. Bucello, R. Zivadinov, B. Weinstock-Guttman (2014)
Characterizing cognitive function during relapse in multiple sclerosisMultiple Sclerosis Journal, 20
A. Stern (2014)
The hospital anxiety and depression scale.Occupational medicine, 64 5
N. Chiaravalloti, N. Moore, O. Nikelshpur, J. DeLuca (2013)
An RCT to treat learning impairment in multiple sclerosisNeurology, 81
L. Charvet, Jie Yang, Michael Shaw, Kathleen Sherman, L. Haider, Jianjin Xu, L. Krupp (2017)
Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trialPLoS ONE, 12
R. Benedict, JA Duquin, S. Jurgensen, R. Rudick, J. Feitcher, F. Munschauer, M. Panzara, B. Weinstock-Guttman (2008)
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening QuestionnaireMultiple Sclerosis, 14
R. Benedict, J. DeLuca, G. Phillips, N. Larocca, Lynn Hudson, R. Rudick (2017)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosisMultiple Sclerosis (Houndmills, Basingstoke, England), 23
N. Lincoln, R. Nair, L. Bradshaw, C. Constantinescu, A. Drummond, Alexandra Erven, Amy Evans, D. Fitzsimmons, A. Montgomery, Miriam Morgan (2015)
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS)Trials, 16
R. Benedict, F. Munschauer, R. Linn, Colleen Miller, E. Murphy, F. Foley, L. Jacobs (2003)
Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaireMultiple Sclerosis, 9
R. Dumont, John Willis, Kathleen Viezel, Jamie Zibulsky (2014)
California Verbal Learning Test, Second Edition
R. Benedict, M. Amato, J. Boringa, B. Brochet, F. Foley, S. Fredrikson, Paivi Hamalainen, H. Hartung, L. Krupp, I. Penner, A. Reder, D. Langdon (2012)
Brief International Cognitive Assessment for MS (BICAMS): international standards for validationBMC Neurology, 12
J. Sonder, J. Burggraaff, D. Knol, C. Polman, B. Uitdehaag (2014)
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosisMultiple Sclerosis Journal, 20
K. Possin, Tacie Moskowitz, S. Erlhoff, Kirsten Rogers, Erica Johnson, Natasha Steele, Joseph Higgins, J. Stiver, A. Alioto, S. Farias, Bruce Miller, K. Rankin (2018)
The Brain Health Assessment for Detecting and Diagnosing Neurocognitive DisordersJournal of the American Geriatrics Society, 66
D. Delis, Jonathan Kramer, E. Kaplan, B. Ober (2016)
The California verbal learning test
C. Polman, S. Reingold, B. Banwell, M. Clanet, Jeffrey Cohen, M. Filippi, K. Fujihara, E. Havrdová, M. Hutchinson, L. Kappos, F. Lublin, X. Montalban, P. O'Connor, M. Sandberg-wollheim, A. Thompson, E. Waubant, B. Weinshenker, J. Wolinsky (2011)
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 69
R. Lyons (2006)
Cochrane Database of Systematic ReviewsProgress in Neurology and Psychiatry, 15
(1997)
Brief visuospatial memory test revised: professional manual. Lutz
E. Rosti-Otajärvi, P. Hämäläinen (2014)
Neuropsychological rehabilitation for multiple sclerosis.The Cochrane database of systematic reviews, 2
L. Ford-Johnson, J. DeLuca, J. Zhang, E. Elovic, J. Lengenfelder, N. Chiaravalloti (2016)
Cognitive effects of modafinil in patients with multiple sclerosis: A clinical trial.Rehabilitation psychology, 61 1
S. Costa, H. Genova, J. DeLuca, N. Chiaravalloti (2017)
Information processing speed in multiple sclerosis: Past, present, and futureMultiple Sclerosis Journal, 23
B. Brochet, M. Deloire, M. Bonnet, E. Salort-Campana, J. Ouallet, K. Petry, V. Dousset (2008)
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal studyMultiple Sclerosis, 14
(2003)
The hospital anxiety and depression scaleHealth Qual Life Outcomes., 1
K. Honarmand, A. Feinstein (2009)
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patientsMultiple Sclerosis, 15
R. Benedict, J. Fischer, C. Archibald, P. Arnett, W. Beatty, J. Bobholz, G. Chelune, J. Fisk, D. Langdon, L. Caruso, F. Foley, N. Larocca, L. Vowels, A. Weinstein, J. DeLuca, Stephen Rao, F. Munschauer (2002)
Minimal Neuropsychological Assessment of MS Patients: A Consensus ApproachThe Clinical Neuropsychologist, 16
C. Potagas, E. Giogkaraki, G. Koutsis, D. Mandellos, E. Tsirempolou, C. Sfagos, D. Vassilopoulos (2008)
Cognitive impairment in different MS subtypes and clinically isolated syndromesJournal of the Neurological Sciences, 267
IntroductionSelf-administered in-home digital therapeutics could expand access to cognitive rehabilitation for individuals with multiple sclerosis (MS), over half of whom experience cognitive impairment (CI). However, feasibility in an MS population must be clarified. This study was conducted to assess the feasibility of deploying a videogame-like digital treatment for CI in MS, including initial efficacy and barriers to adherence.MethodsIn this pilot study, 21 participants with MS completed an in-clinic baseline neurological evaluation. Cognitive tests included paper-and-pencil Brief International Cognitive Assessment for Multiple Sclerosis [BICAMS—which included the Symbol Digit Modalities Test (SDMT)] and other unsupervised tablet-based tests (including Match: an unsupervised test of executive functions and processing speed, developed at UCSF; and the Cogstate MS Battery). Participants then completed an in-home, tablet-based, videogame-like investigational digital treatment (Project: EVO™) for 25 min daily, 5 days weekly, for 4 weeks. This was followed by a repeat in-clinic evaluation.ResultsOf the 21 participants (mean [standard deviation, SD] age 53.8 [11.6] years, median Expanded Disability Status Scale (EDSS) 2.5 [SD 2.0, IQR [2–3.5]]) enrolled to use the digital therapeutic at home (mean [SD] SDMT z score: − 0.21 [1.16]), 18 completed the study, during which they completed an average of 19.7 days (median [SD]: 20.5 [8.4]). Overall, 78% of these 18 participants completed 75% of prescribed days (i.e., at least 15), and 50% completed all 20 days or more. Over the 4-week period, scores of processing speed improved significantly (based on one-sided t test), including SDMT (p = 0.003) and Match (p = 0.006). The Cogstate DET test (psychomotor function) also increased (p = 0.006). Mean increase in SDMT was 3.6 points. Male sex, not being employed, and higher baseline anxiety all were significantly associated with greater improvement in SDMT over the 4-week period. Interestingly, lower baseline cognitive scores were associated with greater number of sessions completed (e.g., SDMT: p = 0.003, R2 = 0.44). Adjusting for employment, a proxy for time available, did not significantly improve the model fit.DiscussionDeploying an in-home digital tool to improve processing speed in MS is feasible, and shows preliminary efficacy. A larger, randomized controlled clinical trial is ongoing.
Neurology and Therapy – Springer Journals
Published: Jun 1, 2019
Keywords: Cognition; Digital health; MHEALTH; Multiple Sclerosis; Processing speed
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.